Cite
Antiparkinsonian drug-induced sleepiness: a double-blind placebo-controlled study of L-dopa, bromocriptine and pramipexole in healthy subjects.
MLA
Micallef, Joëlle, et al. “Antiparkinsonian Drug-Induced Sleepiness: A Double-Blind Placebo-Controlled Study of L-Dopa, Bromocriptine and Pramipexole in Healthy Subjects.” British Journal of Clinical Pharmacology, vol. 67, no. 3, Mar. 2009, pp. 333–40. EBSCOhost, https://doi.org/10.1111/j.1365-2125.2008.03310.x.
APA
Micallef, J., Rey, M., Eusebio, A., Audebert, C., Rouby, F., Jouve, E., Tardieu, S., & Blin, O. (2009). Antiparkinsonian drug-induced sleepiness: a double-blind placebo-controlled study of L-dopa, bromocriptine and pramipexole in healthy subjects. British Journal of Clinical Pharmacology, 67(3), 333–340. https://doi.org/10.1111/j.1365-2125.2008.03310.x
Chicago
Micallef, Joëlle, Marc Rey, Alexandre Eusebio, Christine Audebert, Frank Rouby, Elisabeth Jouve, Sophie Tardieu, and Oliver Blin. 2009. “Antiparkinsonian Drug-Induced Sleepiness: A Double-Blind Placebo-Controlled Study of L-Dopa, Bromocriptine and Pramipexole in Healthy Subjects.” British Journal of Clinical Pharmacology 67 (3): 333–40. doi:10.1111/j.1365-2125.2008.03310.x.